Chelsea DeLeon

Title: Chelsea DeLeon: Innovator in GPER Targeting Compounds

Introduction

Chelsea DeLeon is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of medical research, particularly in the development of compounds targeting GPER for the treatment of various diseases. Her innovative work has the potential to impact the treatment of cancers, cardiovascular diseases, and more.

Latest Patents

Chelsea DeLeon holds 1 patent related to her research. The patent focuses on compounds and methods targeting GPER for the treatment of diseases associated with calcium. This includes compositions and methods aimed at treating cancers such as breast cancers and leukemias, gallstone disease, and cardiovascular disease. Additionally, her work includes high throughput assays for identifying antagonists of GPER, showcasing her commitment to advancing medical science.

Career Highlights

Chelsea is affiliated with Saint Louis University, where she conducts her research and develops her innovative ideas. Her work is characterized by a strong focus on the intersection of chemistry and medicine, aiming to create effective treatments for serious health conditions.

Collaborations

Chelsea collaborates with Christopher Arnatt, enhancing her research efforts and contributing to the advancement of their shared goals in medical innovation.

Conclusion

Chelsea DeLeon is a dedicated inventor whose work in targeting GPER has the potential to revolutionize treatments for various diseases. Her contributions to medical research are invaluable and reflect her commitment to improving health outcomes.